Camp4 Therapeutics Corporation
CAMP
$4.42
$0.020.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -166.39% | -47.44% | -203.37% | -11.98% | -0.09% |
| Total Depreciation and Amortization | 19.77% | 23.52% | -11.00% | -0.48% | 1.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,560.39% | 431.79% | 2,214.66% | 85.98% | 11.77% |
| Change in Net Operating Assets | -727.10% | 76.75% | 5,512.79% | -128.15% | 116.94% |
| Cash from Operations | -22.65% | 23.13% | 155.75% | -15.72% | 23.03% |
| Capital Expenditure | -- | -- | 100.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 91.47% | 45.85% | 135.29% |
| Issuance of Common Stock | -- | -- | -67.29% | 104,948.39% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 213.96% | 7,142.45% | -- |
| Cash from Financing | -94.44% | 137.75% | -60.88% | 12,375.65% | 108.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.73% | 25.77% | -43.30% | 459.19% | 28.74% |